BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30401504)

  • 1. Novel therapeutic targets in autoimmune hepatitis.
    Taubert R; Hupa-Breier KL; Jaeckel E; Manns MP
    J Autoimmun; 2018 Dec; 95():34-46. PubMed ID: 30401504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
    Whitington PF; Vos MB; Bass LM; Melin-Aldana H; Romero R; Roy CC; Alvarez F
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):74-80. PubMed ID: 23969541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
    Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
    J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.
    Mo R; Feng XX; Wu YN; Wang H; He YP; Sun HH; Guo F; Chen Q; Yan W; Li PY; Liu M; Zhang GM; Tian DA; Feng ZH
    Mol Immunol; 2020 Jul; 123():106-115. PubMed ID: 32485469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy.
    Than NN; Jeffery HC; Oo YH
    Can J Gastroenterol Hepatol; 2016; 2016():7181685. PubMed ID: 27446862
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
    Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
    Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.
    Lapierre P; Béland K; Yang R; Alvarez F
    Hepatology; 2013 Jan; 57(1):217-27. PubMed ID: 22911361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile autoimmune hepatitis: A comprehensive review.
    Sokollik C; McLin VA; Vergani D; Terziroli Beretta-Piccoli B; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():69-76. PubMed ID: 30344030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice.
    Wang H; Feng X; Han P; Lei Y; Xia Y; Tian D; Yan W
    Mol Med Rep; 2019 Dec; 20(6):4883-4892. PubMed ID: 31638166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.
    Muratori L; Longhi MS
    J Autoimmun; 2013 Oct; 46():74-80. PubMed ID: 23871639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future perspective: immunomodulatory therapy for autoimmune hepatitis.
    Sebode M; Lohse AW
    Dig Dis; 2014; 32(5):502-6. PubMed ID: 25034282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis: a classic autoimmune liver disease.
    Moy L; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):341-6. PubMed ID: 25466500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements and challenges of a preclinical autoimmune hepatitis mouse model.
    Hardtke-Wolenski M; Noyan F; Jaeckel E
    Dig Dis; 2011; 29(4):402-10. PubMed ID: 21894011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.
    Sirbe C; Simu G; Szabo I; Grama A; Pop TL
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
    Wang H; Feng X; Yan W; Tian D
    Front Immunol; 2020; 11():575572. PubMed ID: 33117375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hepatitis: a comprehensive review.
    Liberal R; Grant CR; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():126-39. PubMed ID: 23218932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis.
    Lapierre P; Béland K; Alvarez F
    Transl Res; 2007 Mar; 149(3):107-13. PubMed ID: 17320796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.